WAY-362450
Catalog No. A11186
WAY-362450是一种高效,选择性和口服可生物利用的法呢类X受体(FXR)激动剂(EC50:4 nM,eff = 149%)。
- Dong-Hyun Kim, .et al. The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD, Cell Death Dis, 2021, Apr; 12(4): 320 PMID: 33767132
- Dong-Hyun Kim, .et al. Src-mediated crosstalk between FXR and YAP protects against renal fibrosis, FASEB J, 2019, Jul 12:fj201900325R PMID: 31298930
Catalog Num | A11186 |
---|---|
M. Wt | 438.47 |
Formula | C25H24F2N2O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 629664-81-9 |
Synonyms | WAY362450, XL335 |
SMILES | CC(C)OC(=O)C1=CN(CC(C2=C1NC3=CC=CC=C32)(C)C)C(=O)C4=CC(=C(C=C4)F)F |
WAY-362450是一种高效,选择性和口服可生物利用的法呢类X受体(FXR)激动剂(EC50:4 nM,eff = 149%)。
Targets
FXR | ||||
4 nM(EC50) |
In vitro (25°C) | DMSO | Warmed: 31 mg/mL (70.7 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (4.56 mM) | ||
In vivo | NMP+PEG300 (10+90, v+v) | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.81 mL | 114.03 mL | 228.07 mL |
0.5 mM | 4.56 mL | 22.81 mL | 45.61 mL |
1 mM | 2.28 mL | 11.4 mL | 22.81 mL |
5 mM | 0.46 mL | 2.28 mL | 4.56 mL |
*The above data is based on the productmolecular weight 438.47. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.